Cargando…

P552: MEASURABLE RESIDUAL DISEASE DETECTED BY WT1 IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN CHILDREN WITH ACUTE MYELOID LEUKEMIA

Detalles Bibliográficos
Autores principales:	Elsherif, Mariam, Ahmed, Sonia, Yassin, Dina, Elsharkawy, Nahla, S Mohamed, Ayman, Yasser, Nouran, Hafez, Hanafy, Elhaddad, Alaa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429564/ http://dx.doi.org/10.1097/01.HS9.0000969116.12080.90

Ejemplares similares

Hematopoietic stem cell transplantation from HLA-matched sibling donors in children with acute lymphoblastic leukemia: A report from the Children’s Cancer Hospital Egypt
por: Hammad, Mahmoud, et al.
Publicado: (2022)

Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia
por: Kamel, Azza M., et al.
Publicado: (2022)

The Role of Wilms’ Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia
por: Lazzarotto, Davide, et al.
Publicado: (2022)

The Methionine 549 and Leucine 552 Residues of Friedelin Synthase from Maytenus ilicifolia Are Important for Substrate Binding Specificity
por: Mazzeu, Bruna F., et al.
Publicado: (2021)

WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients
por: Koczkodaj, Dorota, et al.
Publicado: (2022)

Proteomic Study to Survey the CIGB-552 Antitumor Effect
por: Rodríguez-Ulloa, Arielis, et al.
Publicado: (2015)

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
por: Lambert, Juliette, et al.
Publicado: (2021)

552 Predictors Affecting the Quality of Life of Patients with Bronchial Asthma
por: Jankowska-Polanska, Beata, et al.
Publicado: (2012)

SUN-552 Ectopic Thymoma Masquerading as a Thyroid Mass
por: Nagaraja, Soumya
Publicado: (2019)

Complete Genome Sequence of Aeromonas hydrophila Bacteriophage BUCT552
por: Chen, Rujia, et al.
Publicado: (2022)

Crosstalk between b-catenin and WT1 signaling activity in acute myeloid leukemia
por: Wagstaff, Megan, et al.
Publicado: (2022)

MicroRNA-552 expression in colorectal cancer and its clinicopathological significance
por: Im, Joon, et al.
Publicado: (2021)

WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
por: Liu, Hongtao, et al.
Publicado: (2018)

An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia
por: Nakagawa, Natsuki, et al.
Publicado: (2022)

MicroRNA-552 promotes hepatocellular carcinoma progression by downregulating WIF1
por: Li, Chao, et al.
Publicado: (2018)

MON-552 Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma
por: Akaishi, Junko, et al.
Publicado: (2019)

miR-552: an important post-transcriptional regulator that affects human cancer
por: Zou, Yuhao, et al.
Publicado: (2020)

miR-552 promotes ovarian cancer progression by regulating PTEN pathway
por: Zhao, Wenman, et al.
Publicado: (2019)

552. Could Anticoagulant Use Prior to Infection with COVID-19 Decrease Mortality?
por: Natali, Kayla M, et al.
Publicado: (2020)

THU552 Understanding Radiation Therapy Sensitivity In Invasive Lobular Carcinoma Of The Breast
por: Boysen, Michael Rhinehart, et al.
Publicado: (2023)

Wilms Tumor-1 (WT1) rs16754 Polymorphism and Clinical Outcome in Acute Myeloid Leukemia
por: Ramzi, Mani, et al.
Publicado: (2019)

WT-1, BAALC, and ERG Expressions in Iranian Patients with Acute Myeloid Leukemia Pre- and Post-chemotherapy
por: Mehralizadeh, Hossein, et al.
Publicado: (2021)

WT1 peptide analogue WT1-126Y enhances leukemia lysis
por: Alqudaihi, Ghofran, et al.
Publicado: (2014)

Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014)

Clinical Impact of Overexpression of FOXP3 and WT1 on Disease Outcome in Egyptian Acute Myeloid Leukemia Patients
por: Assem, Magda M, et al.
Publicado: (2016)

CAMAC Dual Fixed Preset Counter (FIPS): (PS-LI 552-002 LE)
por: Knott, J
Publicado: (1984)

miR-552 Regulates Liver Tumor-Initiating Cell Expansion and Sorafenib Resistance
por: Han, Tao, et al.
Publicado: (2020)

552. Within-Host Evaluation of Colonization During Active Methicillin-Resistant S. aureus Bacteremia
por: Berbel Caban, Ana B, et al.
Publicado: (2019)

55.2 CBT: BIOBEHAVIORAL TOOLS FOR PEDIATRIC PAIN MANAGEMENT DURING COVID-19
por: Zoffness, Rachel
Publicado: (2021)

552 DFB: Tiny burn, big problem - the implications of a diabetic foot burn
por: Uche, Stanley, et al.
Publicado: (2022)

Measurable residual disease in chronic myeloid leukemia
por: Branford, Susan, et al.
Publicado: (2022)

Hypoxia-Sensitive Epigenetic Regulation of an Antisense-Oriented lncRNA Controls WT1 Expression in Myeloid Leukemia Cells
por: McCarty, Gregory, et al.
Publicado: (2015)

Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
por: Das, Andrew B., et al.
Publicado: (2019)

WT1 β’ing catenin into shape: a new interaction driving epigenetic plasticity in acute myeloid leukemia?
por: Grey, William
Publicado: (2022)

A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia
por: Chen, Mengting, et al.
Publicado: (2023)

Novel WT1 Target Genes: IL-2, IL-2RB, and IL-2RG Discovered during WT1 Silencing Using Lentiviral-Based RNAi in Myeloid Leukemia Cells
por: Dejjuy, Duangnapa, et al.
Publicado: (2020)

P546: MACHINE LEARNING AND RESPONSE TO INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Elhaddad, Heba, et al.
Publicado: (2023)

EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552
por: Zhu, Xiao‐Xu, et al.
Publicado: (2019)

Cerebral Venous Sinus Thrombosis following COVID-19 Vaccination: Analysis of 552 Worldwide Cases
por: de Gregorio, Cesare, et al.
Publicado: (2022)

WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target
por: Zhou, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_upq265all51ei76d9rspf0n8qe